FR901464 Synthesis via Segmentation and Merging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The synthesis of potent analogs of the natural product FR901464, a potential anticancer agent, is hindered by a lengthy process involving numerous steps, limiting the development of more effective compounds for cancer treatment.
Innovation Solution
Development of novel analogs of FR901464 and new methods for preparing FR901464 and its analogs, including specific compounds and pharmaceutical compositions that conform to specific structural formulas, which are designed to enhance antitumor activity with improved synthesis efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional synthesis methods are used to prepare FR901464 analogs, then antitumor activity can be achieved, but the synthesis process becomes excessively lengthy and complex
Solution Approach 1:
The synthesis is divided into modular segments: (1) preparation of key intermediate compounds with specific stereochemistry, (2) coupling reactions to assemble the macrocyclic core, and (3) final functional group installations. This segmentation allows each step to be optimized independently and facilitates parallel synthesis of different analogs.
Solution Approach 2:
Chiral centers are established early in the synthesis through asymmetric catalysis or chiral pool starting materials, eliminating the need for later stereoselective transformations. Protecting group strategies are predetermined to minimize deprotection/reprotection cycles.
2Reliability
If traditional synthesis methods are used to prepare FR901464 analogs, then potent antitumor compounds can be obtained, but the number of synthesis steps increases to forty or more
Solution Approach 1:
Multiple transformations are combined into single operational steps where possible. For example, one-pot sequences that perform protection, coupling, and deprotection in sequence reduce the total number of isolation and purification steps, directly decreasing the synthesis step count while maintaining analog potency.
3Loss of time
If the synthesis process is simplified, then development time can be reduced, but the ability to produce potent analogs may be compromised
Solution Approach 1:
Reaction conditions are optimized to proceed under milder, faster conditions without sacrificing selectivity. Temperature, solvent, and catalyst parameters are tuned to accelerate rate-determining steps while maintaining the stereochemical integrity and structural precision required for antitumor activity.
Data Source
AI summary
The present invention provides novel analogs of FR901464, as well as an improved methodology for preparing FR901464 and its analogs. These compounds display an anti-cancer activity and are candidates for therapies against a number of disease states associated with dysfunctional RNA splicing.